MAPT and Alzheimer disease: Removal of ASC speck measurements from the (p-tau-AT8 + ASC) / Aβ ratio gave us a significantly reduced AUC of 81% in early AD serum and a slightly lower AUC of 93% in AD moderate dementia (Supplementary Fig. 3E).